TORC-Specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser 2481 is a marker for intact mTOR signaling complex 2

Cancer Research

Volumn 69, Issue 5, 2009, Pages 1821-1827

  Copp, Jeremy ^a   Manning, Gerard ^a   Hunter, Tony ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN SIGNALING COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN SIGNALING COMPLEX 2; PHOSPHOSERINE; PROTEIN; RAPAMYCIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MTORC1 PROTEIN, HUMAN; PROTEIN KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; CYTOSKELETON; EMBRYO; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS; AMINO ACID SEQUENCE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CELLS, CULTURED; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 62449266454     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3014     Document Type: Article

References (28)

1. Hará K, Marukl Y, Long X, et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002;110:177-189
2. Kim. DH, Sarbassov DD, All SM, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002;110:163-175.
3. Kim DH, Sarbassov DD, Ali SM, et al. GfSL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive Interaction between raptor and mTOR. MoI Cell 2003;11:895-904.
4. Haar EY Lee SI, Bandhakavi S, Griffin TJ, Kim DH. InsuUn signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 2007;9:316-323.
5. Tee AR, Blenls J. mTOR, translational control and human disease. Semin CeU Dev Biol 2005;16:29-37.
6. Sarbassov DD, All SM, Kim DH, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regu-lates the cytoskeleton. Curr Biol 2004;14:1.296-302.
7. Frias MA, Thoreen CC, Jaffe JD, et al. inSinl is necessary for Akt/PKB phosphorylation, and its iso-forms define three distinct mTORC2s. Curr Biol 2006:16: 1865-1870.
8. Jacinto E, Facchinetti V, Liu. D, et al. SINl/MIPl. maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 2006;127:125-37.
9. Yang Q, Inoki K, Ikenoue T, Guan KL. Identification of Sinl as an essential TORC2 component required for complex formation and kinase activity. Genes Dev 2006; 20:2820-2832.
10. Pearce LR, Huang X, Boudeau J, et al. Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem. J 2007;405:513-522.
11. Sarbassov DD, Ali SM, Sengupta S, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006;22:159-168.
12. Sarbassov DD, Guertin DA, All SM, Sabatlni DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005;307:1098-1101.
13. Feng J, Park J, Cron P1 Hess D, Hemmings BA. Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem. 2004;279:41189-41196.
14. Viniegra JG, Martinez N, Modirassari P, et al. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem 2005; 280:4029-4036.
15. Bozulic L, Surucu B, Hynx D, Hemmings BA. PKBa/ Aktl acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. MoI. Cell 2008;30:203-213.
16. Shiota C, Woo JT, Lindner J, Shelton KD, Magnuson MA. MultialleUc disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev Cell 2006;11:583-589.
17. Guertin DA, Stevens DM, Thoreen CC, et al. Ablation in mice of the m'i'ORC components raptor, rictor, or mLSTS reveals that mTORC2 is required for signaling to Akt-FOXO and PKCa, but not S6K1. Dev CeU 2006;11:859-871.
18. Cheng SW Fryer LG, Carling D, Shepherd PR. Thr244* is a novel mammalian, target of rapamycin. (mTOR) phosphorylation site regulated by nutrient status. J Biol Chem 2004;279:15719-15722.
19. Chiang GG, Abraham RT. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem. 2005;280: 25485-25490.
20. HoIz MK, Blenis J. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J Biol Chem 2005:280: 26089-26093.
21. Peterson RT, Beal PA, Comb MJ, Schreiber SL. FKBP12-rapamycin-associated protein (FRAP) auto-phosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem 2000;275:7416-7423.
22. Sekulic A, Hudson. CC, Homme JL, et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 2000;60:3504-3513.
23. Harrington LS, Findlay GM, Gray A, et al. The TSC.1-2 tumor suppressor controls insulln-PI3K signal-ing via regulation of 1RS proteins. J Cell Biol 2004:166: 213-223.
24. Shah OJ, Wang Z, Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRSl/2 depletion, insulin resistance, and cell survival deficien-cies. Curr Biol 2004;14:1650-1656.
25. O'Reilly KE, RoJo F, She QB, et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 2006;66:1500-1508.
26. Wang X, Yue P, Kim YA, et al. Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/ rlctor-independent Akt activation. Cancer Res 2008;68: 7409-18.
27. Holz MK, BaIlIf BA, Gygi SP, Blenls J. mTOR and S6.K. 1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 2005:123:569-580.
28. Kannan N, Haste N, Taylor SS, Neuwald AF. The hallmark of AGC kinase functional divergence is Its C--terminal tail, a ds-actlng regulatory module. Proc Natl Acad Sei U S A 2007;104:1272-1277